Free Trial

Bio-Rad Laboratories (BIO) Competitors

Bio-Rad Laboratories logo
$246.31 -3.34 (-1.34%)
As of 07/18/2025 03:59 PM Eastern

BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and A

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Bio-Rad Laboratories vs. Its Competitors

Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

Mettler-Toledo International has a net margin of 22.17% compared to Bio-Rad Laboratories' net margin of -85.16%. Bio-Rad Laboratories' return on equity of 4.32% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Mettler-Toledo International22.17% -556.22% 26.27%
Bio-Rad Laboratories -85.16%4.32%3.03%

Mettler-Toledo International currently has a consensus target price of $1,280.90, suggesting a potential upside of 6.99%. Bio-Rad Laboratories has a consensus target price of $324.25, suggesting a potential upside of 31.64%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mettler-Toledo International
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45
Bio-Rad Laboratories
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are held by institutional investors. 1.9% of Mettler-Toledo International shares are held by company insiders. Comparatively, 17.1% of Bio-Rad Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.87B6.42$863.14M$40.1029.86
Bio-Rad Laboratories$2.57B2.61-$1.84B-$76.20-3.23

In the previous week, Bio-Rad Laboratories had 1 more articles in the media than Mettler-Toledo International. MarketBeat recorded 14 mentions for Bio-Rad Laboratories and 13 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.47 beat Bio-Rad Laboratories' score of 0.69 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mettler-Toledo International
11 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bio-Rad Laboratories
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Mettler-Toledo International has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 11 of the 16 factors compared between the two stocks.

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO vs. The Competition

MetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$6.79B$10.25B$5.55B$20.85B
Dividend YieldN/A2.06%3.75%3.65%
P/E Ratio-3.2316.5828.0127.56
Price / Sales2.6130.02432.8159.11
Price / Cash24.0222.3936.1622.29
Price / Book1.053.578.124.66
Net Income-$1.84B$235.43M$3.25B$994.58M
7 Day Performance-4.29%-1.67%1.68%-0.29%
1 Month Performance6.31%2.91%7.30%4.90%
1 Year Performance-17.02%-16.05%32.89%11.14%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIO
Bio-Rad Laboratories
4.6339 of 5 stars
$246.31
-1.3%
$324.25
+31.6%
-17.9%$6.79B$2.57B-3.237,700
MTD
Mettler-Toledo International
4.0499 of 5 stars
$1,195.06
-2.4%
$1,280.90
+7.2%
-11.8%$24.84B$3.83B29.8017,300Positive News
WAT
Waters
4.8876 of 5 stars
$303.93
-13.9%
$388.94
+28.0%
-7.0%$18.09B$2.98B27.587,600Trending News
Analyst Downgrade
Analyst Revision
High Trading Volume
ILMN
Illumina
4.8473 of 5 stars
$98.53
-0.7%
$125.11
+27.0%
-17.0%$15.60B$4.37B-16.239,030Analyst Revision
TECH
Bio-Techne
4.8713 of 5 stars
$52.62
-2.8%
$70.00
+33.0%
-31.5%$8.25B$1.16B64.173,100Analyst Revision
CRL
Charles River Laboratories International
4.7619 of 5 stars
$158.09
-0.8%
$174.54
+10.4%
-29.3%$7.77B$4.05B-243.2120,100Positive News
BRKR
Bruker
4.9753 of 5 stars
$43.21
-1.3%
$52.89
+22.4%
-35.1%$6.55B$3.37B83.1011,396Analyst Revision
PACB
Pacific Biosciences of California
1.8687 of 5 stars
$1.46
-0.7%
$2.06
+41.2%
-21.0%$438.12M$154.01M-0.52730Positive News
Gap Up
HBIO
Harvard Bioscience
4.2545 of 5 stars
$0.43
-3.2%
$3.00
+596.7%
-85.8%$19.04M$91.40M-0.33490Gap Up
TMO
Thermo Fisher Scientific
4.9933 of 5 stars
$425.44
-2.2%
$600.30
+41.1%
-23.2%$160.60B$42.90B24.95125,000Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
A
Agilent Technologies
4.7731 of 5 stars
$120.10
-2.6%
$139.77
+16.4%
-13.6%$34.12B$6.51B29.6517,900

Related Companies and Tools


This page (NYSE:BIO) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners